Global multi-omics market projected to grow to USD 10.72 billion by 2033

From GlobeNewswire: 2024-05-30 16:00:00

The Global Multi-omics Market is projected to grow from USD 2.59 Billion in 2023 to USD 10.72 Billion by 2033, with a CAGR of 15.26% during the forecast period. Multi-omics involves merging data sets across different omics groups like proteomics, metabolomics, transcriptomics, and genomes to provide insights for personalized healthcare and disease mechanisms. Key competitors are focusing on advancements and strategic partnerships to expand their product offerings. The market is expanding rapidly due to the increasing interest in personalized medicine and the need for new drug discoveries. However, the costly setup and facility expenses, as well as regulatory compliance and patient privacy concerns, pose challenges to wider adoption of multi-omics. North America currently dominates the market, while the Asia-Pacific region is expected to experience the fastest growth during the forecast period. Major vendors in the market include Illumina, Inc., PerkinElmer Inc., Bruker, BD, QIAGEN, and Thermo Fisher Scientific Inc. Recent developments in the market include the acquisition of Avida Biomed by Agilent Technologies, Inc. The market is segmented by type, platform, application, and region. The report provides a detailed analysis of key companies involved in the market. For more information, visit the Spherical Insights website.



Read more at GlobeNewswire: Global Multi-Omics Market Size To Exceed USD 10.72 Billion